In This Article:
Directa Plus (LON:DCTA) First Half 2024 Results
Key Financial Results
-
Revenue: €3.39m (down 26% from 1H 2023).
-
Net loss: €2.47m (loss widened by 34% from 1H 2023).
-
€0.037 loss per share (further deteriorated from €0.028 loss in 1H 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Directa Plus Earnings Insights
Looking ahead, revenue is forecast to grow 43% p.a. on average during the next 3 years, compared to a 5.4% decline forecast for the Chemicals industry in the United Kingdom.
Performance of the British Chemicals industry.
The company's shares are down 21% from a week ago.
Risk Analysis
Before you take the next step you should know about the 5 warning signs for Directa Plus (3 are a bit unpleasant!) that we have uncovered.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.